Related Experiment Videos
Current treatments for radiation retinopathy
Gian Paolo Giuliari1, Ama Sadaka, David M Hinkle
1Princess Margaret Hospital, University of Toronto, Department of Ophthalmology and Vision Sciences, Hospital Health Network, Toronto, Ontario, Canada. gpgiuliari@gmail.com
Acta Oncologica (Stockholm, Sweden)
|August 21, 2010
Summary
Radiation retinopathy (RR) is a serious complication of radiation therapy, often leading to vision loss. Current treatments for RR are limited and yield unsatisfactory outcomes, necessitating further research for improved strategies.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Medical Research
Background:
- Radiation retinopathy (RR) is a refractory complication following radiation therapy for intraocular and extraocular tumors.
- The incidence of RR increases with plaque brachytherapy for choroidal melanomas, affecting up to 60% of treated eyes.
- RR presents as radiation vasculopathy, progressing to macular edema, neovascularization, and retinal detachment.
Purpose of the Study:
- To review current therapeutic modalities for radiation retinopathy (RR).
- To examine investigational interventions targeting RR pathophysiology.
- To highlight the limitations of existing treatments for this complication.
Main Methods:
- A comprehensive literature review was conducted.
- The review encompassed the pathogenesis of RR and available therapeutic options.
- Included were studies on both established and emerging treatments.
Main Results:
- RR is a chronic, progressive condition with limited management options.
- Traditional treatments like photodynamic therapy and laser photocoagulation show inconclusive results.
- Intravitreal anti-VEGF agents (bevacizumab, ranibizumab, pegaptanib sodium) have variable efficacy.
Conclusions:
- Radiation retinopathy is a common, vision-threatening complication of radiation therapy.
- Current therapeutic options for RR are limited and provide unsatisfactory results.
- Further research is essential to develop improved therapeutic and preventive strategies for RR.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...